These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22026300)

  • 1. Survival predictors of patients with primary duodenal adenocarcinoma.
    Kawahira H; Miura F; Saigo K; Matsunaga A; Natsume T; Akai T; Horibe D; Suzuki K; Nabeya Y; Hayashi H; Miyauchi H; Shuto K; Asano T; Matsubara H
    Int Surg; 2011; 96(2):111-6. PubMed ID: 22026300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes in patients with duodenal adenocarcinoma.
    Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
    ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of radical resection for locally advanced duodenal adenocarcinoma.
    Bucher P; Gervaz P; Morel P
    Hepatogastroenterology; 2005; 52(66):1727-9. PubMed ID: 16334766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
    Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
    Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The surgical treatment and outcome for primary duodenal adenocarcinoma.
    Han SL; Cheng J; Zhou HZ; Zeng QQ; Lan SH
    J Gastrointest Cancer; 2009; 40(1-2):33-7. PubMed ID: 19513860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What prognostic factors are important in duodenal adenocarcinoma?
    Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
    Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The surgical treatment and outcome for primary duodenal adenocarcinoma.
    Han SL; Cheng J; Zhou HZ; Zeng QQ; Lan SH
    J Gastrointest Cancer; 2010 Dec; 41(4):243-7. PubMed ID: 20431961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the duodenum: factors influencing long-term survival.
    Sohn TA; Lillemoe KD; Cameron JL; Pitt HA; Kaufman HS; Hruban RH; Yeo CJ
    J Gastrointest Surg; 1998; 2(1):79-87. PubMed ID: 9841972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.
    Rose DM; Hochwald SN; Klimstra DS; Brennan MF
    J Am Coll Surg; 1996 Aug; 183(2):89-96. PubMed ID: 8696551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical procedure depending on the depth of tumor invasion in duodenal cancer.
    Kato Y; Takahashi S; Kinoshita T; Shibasaki H; Gotohda N; Konishi M
    Jpn J Clin Oncol; 2014 Mar; 44(3):224-31. PubMed ID: 24470586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenocarcinoma of the distal duodenum: two cases managed by pylorus preserving pancreatico-duodenectomy and adjuvant chemotherapy.
    Fon LJ; Deans GT; Gilroy D; Diamond T
    Ulster Med J; 1994 Oct; 63(2):241-5. PubMed ID: 8650839
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients.
    Santoro E; Sacchi M; Scutari F; Carboni F; Graziano F
    Hepatogastroenterology; 1997; 44(16):1157-63. PubMed ID: 9261617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal adenocarcinoma: Surgical results of 27 patients treated at a single center.
    López-Domínguez J; Busquets J; Secanella L; Peláez N; Serrano T; Fabregat J
    Cir Esp (Engl Ed); 2019 Nov; 97(9):523-530. PubMed ID: 31563268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
    Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
    Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of curative and palliative treatment of duodenal adenocarcinoma].
    Bendixen M; Dahl S; Fristrup C; Mortensen MB
    Ugeskr Laeger; 2010 May; 172(18):1376-9. PubMed ID: 20444409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for primary duodenal adenocarcinoma.
    Lee HG; You DD; Paik KY; Heo JS; Choi SH; Choi DW
    World J Surg; 2008 Oct; 32(10):2246-52. PubMed ID: 18668288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic outcomes of endoscopic resection for superficial non-ampullary duodenal tumor.
    Yamamoto Y; Yoshizawa N; Tomida H; Fujisaki J; Igarashi M
    Dig Endosc; 2014 Apr; 26 Suppl 2():50-6. PubMed ID: 24750149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
    Tsao JI; Rossi RL; Lowell JA
    Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?
    Sakamoto T; Saiura A; Ono Y; Mise Y; Inoue Y; Ishizawa T; Takahashi Y; Ito H
    Ann Surg Oncol; 2017 Oct; 24(11):3368-3375. PubMed ID: 28799027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.